Primarily focus on Canaan鈥檚 healthcare investment efforts and in identifying strategic opportunities within the biotechnology, pharmaceutical and medical devices industries.
Clinical program development and building strategic alliances for 2020 BioVentures in the rare and developing world diseases.
We鈥檝e updated our privacy policy so that we are compliant with changing global privacy regulations and to provide you with insight into the limited ways in which we use your data.
You can read the details below. By accepting, you agree to the updated privacy policy.
